Effect of β2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease

European Journal of Clinical Pharmacology

Volumn 49, Issue 5, 1996, Pages 341-345

  Yang, C T ^a   Lin, H C ^a   Lin, M C ^a   Wang, C H ^a   Lee, C H ^a   Kuo, H P ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Exercise; Fenoterol; Hypokalaemia; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; SALBUTAMOL;

ADULT; AGED; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030029245     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00203774     Document Type: Article

References (24)

1. Crane J, Pearce N, Flatt A (1989) Prescribed fenoterol and death from asthma in New Zealand. Lancet 1: 917-922
2. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS (1992) The use of β-agonist and the risk of death and near death from asthma. N Engl J Med 326: 501-506
3. Flatt A, Crane J, Puride G, Kwong T, Beasley R, Burgess C (1990) The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J 66: 98-101
4. Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N (1992) Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med 86: 419-423
5. Struthers AD, Reid JL (1984) The role of adrenal medullary catecholamines in potassium homeostasis. Clin Sci 66: 377-382
6. Kuschinsky W, Wahl M (1977) Interactions between perivascular norepinephrine and potassium or osmolarity on pial arteries of cats. Microvasc Res 14: 173-180
7. Paterson DJ (1992) Potassium and ventilation in exercise. J Appl Physiol 72: 811-820
8. Siegel G, Schneider W (1981) Anions, cations, membrane potential, and relaxation. In: Vanhoutte PM, Leusen I (ed) Vasodilatation. Raven Press, New York, pp 285-298
9. Laso FJ, Gonzalez-Buitrago JM, Ruiz CM, Castro S (1991) Hormonal regulation of potassium shifts during graded exhausting exercise. Eur J Appl Physiol 62: 292-296
10. Young DB, Srivastava TN, Fitzovich DE, Kivlighn SD, Hamaguchi M (1992) Potassium and catecholamine concentrations in the immediate post exercise period. Am J Med Sci 304: 150-153
11. Coplan NL, Gleim GW, Nicholas JA (1989) Exercise-related changes in serum catecholamines and potassium: effect of sustained exercise above and below lactate threshold. Am Heart J 117: 1070-1075
12. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE (1990) Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336: 1396-1399
13. American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136: 225-244
14. Douglas NJ, Davidson I, Sudlow MF, Flenley DC (1979) Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax 34: 51-56
15. American Association for Respiratory Care (1992) AARC Clinical Practice Guideline: bronchial provocation. Respir Care 37: 902-906
16. McPherson SP, Spearman CB (1990) Humidifiers and neubulizers. In: Respiratory therapy equipment. Mosby US, pp 79-107
17. Phipps PR, Gonda I, Anderson SD, Bailey D, Bautovich G (1994) Regional deposition of saline aerosols of different tonicities in normal and asthmatic subjects. Eur Respir J 7: 1474-1482
18. 2-adrenoceptor agonists. Eur J Clin Pharmacol 36: 415-417
19. Goldman MJ (1986) Definitions of electrocardiographic configurations. In: Principles of clinical electrocardiography. Lange Medical Publications, California, pp 23-28
20. Burdon JGW, Juniper EF, Killian KJ, Hargreave FE, Campbell EJM (1982) The perception of breathlessness in asthma. Am Rev Respir Dis 126: 825-828
21. Dimsdale JE, Hartley LH, Guiney T, Ruskin JN, Greenblatt D (1984) Postexercise peril. JAMA 251: 630-632
22. Windom HH, Burgess CD, Siebers RWL, Purdie G, Pearce N, Crane J, Beasley R (1990) The pulmonary and extrapulmonary effects of inhaled β-agonists in patients with asthma. Clin Pharmacol Ther 48: 296-301
23. Tandon MK (1980) Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest 77: 429-431
24. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenergic agonists and theophylline. Br J Clin Pharmacol 22: 669-676